AIDS vaccination

Concepts in Vaccine Development

Volumn , Issue , 2012, Pages 533-558

  Norley, Stephen ^a   Kurth, Reinhard ^a  

^a PAUL EHRLICH INSTITUT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0007607678     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (153)

1. Agy, M. B., Frumkin, L. R., Corey, L., Coombs, R. W., Wolinsky, S. M., Koehler, J., Morton, W. R., and Katze, M. G. (1992) Infection of Macaca nemestrina by human immunodeficiency virus type-1. Science 257, 103-106
2. Alexander, L., Lu, H. H., Gromeier, M., and Wimmer, E. (1994) Dicistronic polioviruses as expression vectors for foreign genes. AIDS Res. Hum. Retroviruses 10 Suppl 2, 57-60
3. Alter, H. J., Eichberg, J. W., Masur, H., Saxinger, W. C., Gallo, R., Macher, A. M., Lane, H. C., and Fauci, A. S. (1984) Transmission of HTLV-III infection from human plasma to chimpanzees: an animal model for AIDS. Science 226, 549-552
4. Arthur, L. O., Bess, J. W., Urban, R. G., Strominger, J. L., Morton, W. R., Mann, D. L., Henderson, L. E., and Benveniste, R. E. (1995) Macaques immunized with HLA-DR are protected from challenge with simian immunodeficiency virus. J. Virol. 69, 3117-3124
5. Baba, T. W., Jeong, Y. S., Penninck, D., Bronson, R., Greene, M. F., and Ruprecht, R. M. (1995) Pathogenicity of live attenuated SIV after mucosal infection of neonatal macaques. Science 267, 1820-1825
6. Bachmann, M. H., Delwart, E. L., Shpaer, E. G., Lingenfelter, P., Singal, R., and Mullins, J. I. (1994) Rapid genetic characterization of HIV type 1 strains from four World Health Organization-sponsored vaccine evaluation sites using a heteroduplex mobility assay. WHO Network for HIV Isolation and Characterization. AIDS Res. Hum. Retroviruses 10, 1345-1353
7. Banapour, B., Sernatinger, J., and Levy, J. A. (1986) The AIDS-associated retrovirus is not sensitive to lysis or inactivation by human serum. Virology 152, 268-271
8. Bartholomew, R. M., Esser, A. F., and Mueller-Eberhard, H. J. (1978) Lysis of oncornaviruses by human serum. Isolation of the viral complement (CI) receptor and identification as pl5E. J. Exp. Med. 147, 844-853
9. Beer, B., Norley, S., Ennen, J., Plesker, R., Cichutek, K., and Kurth, R. (1995) Control of initial viremia correlates with the development of humoral immune response after SIVmac infection of rhesus macaques. AIDS (Submitted)
10. Berman, R W., Gregory, T. J., Riddle, L., Nakamura, G. R., Champe, M. A., Porter, J. R, Wurm, F. M., Hershberg, R. D., Cobb, E. K., and Eichberg, J. W. (1990) Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gpl20 but not gpl60. Nature 345, 622-625
11. Bobkov, A., Cheingsong, P. R., Garaev, M., Rzhaninova, A., Kaleebu, P., Beddows, S., Bachmann, M. H., Mullins, J. I., Louwagie, J., Janssens, W., van der Groen, G., McCutchan, F., and Weber, J. (1994) Identification of an env G subtype and heterogeneity of HIV-1 strains in the Russian Federation and Belarus. AIDS 8, 1649-1655
12. Borrow, P., Lewicki, H., Hahn, B. H., Shaw, G. M., and Oldstone, M. B. (1994) Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J. Virol. 68, 6103-6110
13. Bou-Habib, D. C, Roderiquez, G., Oravecz, T., Berman, P. W., Lusso, P., and Norcross, M. A. (1994) Cryptic nature of envelope V3 region epitopes protects primary monocytotropic human immunodeficiency virus type 1 from antibody neutralization. J. Virol. 68, 6006-6013
14. Broliden, P. A., Maekitalo, B., Akerblom, L., Rosen, J., Broliden, K., Utter, G., Jondal, M., Norrby, E., and Wahren, B. (1991) Identification of amino acids in the V3 region of gpl20 critical for virus neutralization by human HIV-1-specific antibodies. Immunol. 73, 371-376
15. Burton, D. R., Pyati, J., Koduri, R., Sharp, S. J., Thornton, G. B., Parren, P., Sawyer, L., Hendry, R. M., Dunlop, N., Nara, P. L., Lamacchia, M., Garratty, E., Stiehm, E. R., Bryson, Y. J., Cao, Y. Z., Moore, J. P., Ho, D. D., and Barbas, C. F. (1994) Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody. Science 266, 1024-1027
16. Buseyne, F., McChesney, M., Porrot, F., Kovarik, S., Guy, B., and Riviere, Y. (1993) Gagspecific cytotoxic T lymphocytes from human immunodeficiency virus type 1-infected individuals: Gag epitopes are clustered in three regions of the p24gag protein. J. Virol. 67, 694-702
17. Castro, B. A., Nepomuceno, M., Lerche, N. W., Eichberg, J. W., and Levy, J. A. (1991) Persistent infection of baboons and rhesus monkeys with different strains of HIV-2. Virology 184, 219-226
18. Cernescu, C. E., Tardei, G., Necula, A., Ruta, S. M., and Pau, C. P. (1994) The serologic significance of F viral genotype for human immunodeficiency virus type 1 epidemic. J. Infect. Dis. 170, 1043-1044
19. Chalifoux, L. V., Ringler, D. J., King, N. W., Sehgal, P. K., Desrosiers, R. C., Daniel, M. D., and Letvin, N. L. (1987) Lymphadenopathy in macaques experimentally infected with the simian immunodeficiency virus (SIV). Am J Pathol 128, 104-110
20. Chamat, S., Nara, P., Berquist, L., Whalley, A., Morrow, W. J., Koehler, H., and Kang, C. Y. (1992) Two major groups of neutralizing anti-gpl20 antibodies exist in HIV-infected individuals. Evidence for epitope diversity around the CD4 attachment site. J. Immunol. 149, 649-654
21. Chanda, P. K., Natuk, R. J., Mason, B. B., Bhat, B. M., Greenberg, L., Dheer, S. K., Molnar-Kimber, K. L., Mizutani, S., Lübeck, M. D., Davis, A. R., and Hung, P. P. (1990) High level expression of the envelope glycoproteins of the human immunodeficiency virus type I in presence of rev gene using helper-independent adenovirus type 7 recombinants. Virology 175, 535-547
22. Cichutek, K., Merget, H., Norley, S., Linde, R., Kreuz, W., Gahr, M., and Kurth, R. (1992) Development of a quasispecies of human immunodeficiency virus type 1 in vivo. Proc. Natl. Acad. Sci. USA 89, 7365-7369
23. Clerici, M., Lucey, D. R., Zajac, R. A., Boswell, R. N., Gebel, H. M., Takahashi, H., Berzofsky, J. A., and Shearer, G. M. (1991) Detection of cytotoxic T lymphocytes specific for synthetic peptides of gpl60 in HIV-seropositive individuals. J. Immunol. 146, 2214-2219
24. Cooney, E. L., Collier, A. C., Greenberg, P. D., Coombs, R. W., Zarling, J., Arditti, D. E., Hoffman, M. C., Hu, S. L., and Corey, L. (1991) Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoprotein. Lancet 337, 567-572
25. Cooney, E. L., McElrath, M. J., Corey, L., Hu, S. L., Collier, A. C., and Arditti, D. (1993) Enhanced immunity to human immunodeficiency virus (HIV) envelope elicited by a combined vaccine regimen consisting of priming with a vaccinia recombinant expressing HIV envelope and boosting with gpl60 protein. Proc. Natl. Acad. Sci. USA 90, 1882-1886
26. Cranage, M. P., Ashworth, L. A., Greenaway, P. J., Murphey-Corb, M., and Desrosiers, R. C. (1992) AIDS vaccine developments. Nature 355, 685-686
27. Culmann, B., Gomard, E., Kieny, M. P., Guy, B., Dreyfus, F., Saimot, A. G., Sereni, D., Sicard, D., and Levy, J. P. (1991) Six epitopes reacting with human cytotoxic CD8+ T cells in the central region of the HIV-1 NEF protein. J. Immunol. 146, 1560-1565
28. Daniel, M. D., Kirchhoff, F., Czajak, S. C., Sehgal, P. K., and Desrosiers, R. C. (1992) Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 258, 1938-1941
29. Desrosiers, R. C. (1988) Simian immunodeficiency viruses. Annu Rev Microbiol 42, 607-625
30. Desrosiers, R. C., Wyand, M. S., Kodama, T., Ringler, D. J., Arthur, L. O., Sehgal, P. K., Letvin, N. L., King, N. W., and Daniel, M. D. (1989) Vaccine protection against simian immunodeficiency virus infection. Proc. Natl. Acad. Sci. USA 86, 6353-6357
31. Donnelly, J. J., Ulmer, J. B., and Liu, M. A. (1994) Immunization with DNA. J. Immunol. Methods. 176, 145-152
32. Dormont, D., Legrand, R., Cranage, M., Greenaway, P., Hunsmann, G., Stahlhennig, C., Rossi, G., Verani, P., Stott, J., Kitchin, P., Osterhaus, A., Devries, P., Kurth, R., Norley, S., Heeney, J., Biberfeld, G., and Putkonen, P. (1995) Protection of macaques against simian immunodeficiency virus infection with inactivated vaccines: Comparison of adjuvants, doses and challenge viruses. Vaccine 13, 295-300
33. Dormont, D., Livartowski, J., Chamaret, S., Guetard, D., Henin, D., Levagueresse, R., van de Moortelle, P. F., Larke, B., Gourmelon, P., Vazeux, R. et al. (1989) HIV-2 in rhesus monkeys: serological, virological and clinical results. Intervirology 30, 59-65
34. Dumitrescu, O., Kalish, M. L., Kliks, S. C., Bandea, C. I., and Levy, J. A. (1994) Characterization of human immunodeficiency virus type 1 isolates from children in Romania: identification of a new envelope subtype. J. Infect. Dis. 169, 281-288
35. Evans, D. J., McKeating, J., Meredith, J. M., Burke, K. L., Katrak, K., John, A., Ferguson, M., Minor, P. D., Weiss, R. A., and Almond, J. W. (1989) An engineered poliovirus chimaera elicits broadly reactive HIV-1 neutralizing antibodies. Nature 339, 385-388
36. Fish, D. C., Gilden, R. V., Bare, R. M., Trimmer, R. M., and Huebner, R. J. (1979) Prevention of spontaneous leukemia in AKR mice by passive immunization and type specificity of this protection. J. Natl. Cancer. Inst. 62, 943-945
37. Frumkin, L. R., Agy, M. B., Coombs, R. W., Panther, L., Morton, W. R., and Koehler, J. (1993) Acute infection of Macaca nemestrina by human immunodeficiency virus type 1. Virology 195, 422-431
38. Fultz, P. N., Gordon, T. P., Anderson, D. C., and McClure, H. M. (1990) Prevalence of natural infection with simian immunodeficiency virus and simian T-cell leukemia virus type I in a breeding colony of sooty mangabey monkeys. AIDS 4, 619-625
39. Fynan, E. F., Robinson, H. L., and Webster, R. G. (1993a) Use of DNA encoding influenza hemagglutinin as an avian influenza vaccine. DNA Cell Biol 12, 785-789
40. Fynan, E. F., Webster, R. G., Fuller, D. H., Haynes, J. R., Santoro, J. C., and Robinson, H. L. (1993b) DNA vaccines: protective immunizations by parenteral, mucosal, and genegun inoculations. Proc. Natl. Acad. Sci. USA 90, 11478-11482
41. Gao, F., Yue, L., Craig, S., Thornton, C. L., Robertson, D. L., Mccutchan, F. E., Bradac, J. A., Sharp, P. M., Hahn, B. H., Osmanov, S., Belsey, E. M., Heyward, W., Esparza, J., Galvaocastro, B., Vandeperre, P., Karita, E., Wasi, C., Sempala, S., Tugume, B., Biryahwaho, B., Rubsamenwaigmann, H., Vonbriesen, H., Esser, R., Grez, M., Holmes, H., Newberry, A., Ranjbar, S., Tomlinson, P., Bradac, J., Mccutchan, F., Louwagie, J., Hegerich, P., Lopezgalindez, C., Olivares, I., Dopazo, J., Mullins, J. I., Delwart, E. L., Bachmann, H. M., Goudsmit, J., Dewolf, F., Saragosti, S., Schochetman, G., Kalish, M., Luo, C. C., George, R., Pau, C. P., Weber, J., Cheingsongpopov, R., Kaleebu, P. et al. (1994) Genetic variation of HIV type 1 in four World Health Organization-sponsored vaccine evaluation sites: Generation of functional envelope (glycoprotein 160) clones representative of sequence subtypes A, B, C, and E. AIDS Res. Hum. Retroviruses 10, 1359-1368
42. Giavedoni, L. D., Planelles, V., Haigwood, N. L., Ahmad, S., Kluge, J. D., Marthas, M. L., Gardner, M. B., Luciw, P. A., and Yilma, T. D. (1993) Immune response of rhesus macaques to recombinant simian immunodeficiency virus gpl30 does not protect from challenge infection. J. Virol. 67, 577-583
43. Graham, B. S., Belshe, R. B., Clements, M. L., Dolin, R., Corey, L., Wright, P. F., Gorse, G. J., Midthun, K., Keefer, M. C., Roberts, N. J., Agosti, J. M., Fernie, B. F., Stablein, J. S., Montefiori, D. C., Lambert, J. S., Hu, S. L., Esterlitz, J. R., Lawrence, D. N., and Koff, W. C. (1992) Vaccination of vaccinia-naive adults with human immunodeficiency virus type 1 gpl60 recombinant vaccinia virus in a blinded, controlled, randomized clinical trial. J. Infect. Dis. 166, 244-252
44. Graham, B. S., Matthews, T. J., Belshe, R. B., Clements, M. L., Dolin, R., Wright, P. F., Gorse, G. J., Schwartz, D. H., Keefer, M. C., Bolognesi, D. P., Corey, L., Stablein, D. M., Esterlitz, J. R., Hu, S. L., Smith, G. E., Fast, P. E., and Koff, W. C. (1993) Augmentation of human immunodeficiency virus type 1 neutralizing antibody by priming with gpl60 recombinant vaccinia and boosting with rgpl60 in vaccinia-naive adults. The NIAID AIDS Vaccine Clinical Trials Network. J. Infect. Dis. 167, 533-537
45. Gregersen, J. P., Mehdi, S., Baur, A., and Hilfenhaus, J. (1990) Antibody-and complementmediated lysis of HIV-infected cells and inhibition of viral replication. J Med Virol 30, 287-293
46. Haffar, O., Garrigues, J., Travis, B., Moran, P., Zarling, J., and Hu, S. L. (1990) Human immunodeficiency virus-like, nonreplicating, gag-env particles assemble in a recombinant vaccinia virus expression system. J. Virol. 64, 2653-2659
47. Hahn, B. H., Shaw, G. M., Arya, S. K., Popovic, M., Gallo, R. C., and Wong-Staal, F. (1984) Molecular cloning and characterization of the HTLV-III virus associated with AIDS. Nature 312, 166-169
48. Hart, M. K., Palker, T. J., Matthews, T. J., Langlois, A. J., Lerche, N. W., Martin, M. E., Scearce, R. M., McDanal, C., Bolognesi, D. P., and Haynes, B. F. (1990) Synthetic peptides containing B and T cell epitopes from human immunodeficiency virus envelope gpl20 induce anti-HIV proliferative responses and high titers of neutralizing antibodies in rhesus monkeys. J. Immunol. 145, 2677-2685
49. Härtung, S., Norley, S. G., Ennen, J., Cichutek, K., Plesker, R., and Kurth, R. (1992) Vaccine protection against SIVmac infection by high-but not low-dose whole inactivated virus immunogen. J. AIDS 5, 461-468
50. Hirsch, V. M., Olmsted, R. A., Murphey-Corb, M., Purcell, R. H., and Johnson, P. R. (1989) An African primate lentivirus (SIVsm) closely related to HIV-2. Nature 339, 389-392
51. Hirsch, V. M., Sutter, G., Goldstein, S., Lifson, J., Moss, B., Chanock, R., Sissler, J., and Fuerst, T. (1994) Limited virus replication following homologous uncloned SIV challenge of macaques immunized with attenuated MVA vaccinia expressing SIV env and gag-pol. Seventh Annual Meeting of the National Cooperative Vaccine Development Groups for AIDS 117
52. Hoffenbach, H., Langlade-Demoyen, P., Dadaglio, G., Vilmer, E., Michel, F., Mayaud, C., Autran, B., and Plata, F. (1989) Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans. J. Immunol. 142, 452-462
53. Hoshino, H., Tanaka, H., Miwa, M., and Okada, H. (1984) Human T-cell leukaemia virus is not lysed by human serum. Nature 310, 324-325
54. Hu, S. L., Abrams, K., Barber, G. N., Moran, P., Zarling, J. M., Langlois, A. J., Kuller, L., Morton, W. R., and Benveniste, R. E. (1992a) Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gpl60. Science 255, 456-459
55. Hu, S. L., Abrams, K., Misher, L., Stallard, V., Moran, P., Zarling, J. M., Langlois, A. J., Kuller, L., Morton, W. R., and Benveniste, R. E. (1992b) Evaluation of protective efficacy of recombinant subunit vaccines against simian immunodeficiency virus infection of macaques. J. Med. Primatol. 21, 119-125
56. Hu, S. L., Travis, B. M., Stallard, V., Abrams, K., Misher, L., Moran, P., Zarling, J. M., Langlois, A. J., Kuller, L., Morton, W. R. et al. (1992c) Immune responses to SIVmne envelope glycoproteins protect macaques from homologous SIV infection. AIDS Res. Hum. Retroviruses 8, 1489-1494
57. Hu, S. L., Zarling, J. M., Chinn, J., Travis, B. M., Moran, P. A., Sias, J., Kuller, L., Morton, W. R., Heidecker, G., and Benveniste, R. E. (1989) Protection of macaques against simian AIDS by immunization with a recombinant vaccinia virus expressing the envelope glycoproteins of simian type D retrovirus. Proc. Natl. Acad. Sci. USA 86, 7213-7217
58. Hunsmann, G., Moennig, V., and Schaefer, W. (1975a) Properties of mouse leukemia viruses. IX. Active and passive immunization of mice against Friend leukemia with isolated viral GP71 glycoprotein and its corresponding antiserum. Virology 66, 327-329
59. Hunsmann, G., Moennig, V., Seifert, E., and Schaefer, W. (1975b) Protection of mice against Friend leukemia by active and passive immunization with isolated viral glycoprotein and its antiserum respectively. Zeitschr. Naturforsch. 30c, 309-310
60. Israel, Z. R., Edmonson, P. F., Maul, D. H., O'Neil, S. P., Mossman, S. P., Thiriart, C., Fabry, L., van Opstal, O., Bruck, C., Bex, F., Burney, A., Fultz, P., Mullins, J. I., and Hoover, E. A. (1994) Incomplete protection, but suppression of virus burden, elicited by subunit simian immunodeficiency virus vaccines. J. Virol. 68, 1843-1853
61. Javaherian, K., Langlois, A. J., LaRosa, G. J., Profy, A. T., Bolognesi, D. P., Herlihy, W. C., Putney, S. D., and Matthews, T. J. (1990) Broadly neutralizing antibodies elicited by the hypervariable neutralizing determinant of HIV-1. Science 250, 1590-1593
62. Javaherian, K., Langlois, A. J., McDanal, C., Ross, K. L., Eckler, L. I., Jellis, C. L., Profy, A. T., Rusche, J. R., Bolognesi, D. P., Putney, S. D., and Matthews, T. J. (1989) Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein. Proc. Natl. Acad. Sci. USA 86, 6768-6772
63. Johnson, P. R., Montefiori, D. C., Goldstein, S., Hamm, T. E., Zhou, J., Kitov, S., Haigwood, N. L., Misher, L., London, W. T., Gerin, J. L., Allison, A., Purcell, R. H., Chanock, R. M., and Hirsch, V. M. (1992) Inactivated whole-virus vaccine derived from a proviral DNA clone of simian immunodeficiency virus induces high levels of neutralizing antibodies and confers protection against heterologous challenge. Proc. Natl. Acad. Sci. USA 89, 2175-2179
64. Johnson, R. P., Trocha, A., Buchanan, T. M., and Walker, B. D. (1993) Recognition of a highly conserved region of human immunodeficiency virus type 1 gpl20 by an HLA-Cw4-restricted cytotoxic T-lymphocyte clone. J. Virol. 67, 438-445
65. Karacostas, V., Nagashima, K., Gonda, M. A., and Moss, B. (1989) Human immunodeficiency virus-like particles produced by a vaccinia virus expression vector. Proc. Natl. Acad. Sci. USA 86, 8964-8967
66. Katongole-Mbidde, E. (1993) Expectations of host countries in HIV vaccine trials. AIDS Res. Hum. Retroviruses 9 (Suppl 1), S17-S18
67. Kent, S. J., Corey, L., Agy, M. B., Morton, W. R., Mcelrath, M. J., and Greenberg, P. D. (1995) Cytotoxic and proliferative T cell responses in HIV-1-infected Macaca nemestrina. J. Clin. Invest. 95, 248-256
68. Kestler, H. W., Ringler, D. J., Mori, K., Panicali, D. L., Sehgal, P. K., Daniel, M. D., and Desrosiers, R. C. (1991) Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65, 651-662
69. Korber, B. T. M., Osmanov, S., Esparza, J., Myers, G., Belsey, E. M., Heyward, W., Galvaocastro, B., Vandeperre, P., Karita, E., Wasi, C., Sempala, S., Tugume, B., Biryahwaho, B., Rubsamen-Waigmann, H., Vonbriesen, H., Esser, R., Grez, M., Holmes, H., Newberry, A., Ranjbar, S., Tomlinson, P., Bradac, J., McCutchan, F., Louwagie, J., Hegerich, P., Lopezgalindez, C., Olivares, I., Dopazo, J., Mullins, J. I., Delwart, E. L., Bachmann, H. M., Goudsmit, J., Dewolf, F., Hahn, B. H., Gao, F., Yue, L., Saragosti, S., Schochetman, G., Kalish, M., Luo, C. C., George, R., Pau, C. P., Weber, J., Cheingsongpopov, R., Kaleebu, P., Nara, P., Fenyo, E. M., Albert, J., and Korber, B. (1994) The World Health Organization Global Programme on AIDS proposal for standardization of HIV sequence nomenclature. AIDS Res. Hum. Retroviruses 10, 1355-1358
70. Koup, R. A., Safrit, J. T., Cao, Y., Andrews, C. A., McLeod, G., Borkowsky, W., Farthing, C., and Ho, D. D. (1994) Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68, 4650-4655
71. Kurth, R., Kraus, G., Werner, A., Härtung, S., Centner, P., Baier, M., Norley, S., and Loewer, J. (1988) AIDS: animal retrovirus models and vaccines. J. AIDS 1, 284-294
72. Letvin, N. L., Daniel, M. D., Sehgal, P. K., Desrosiers, R. C., Hunt, R. D., Waldron, L. M., MacKey, J. J., Schmidt, D. K., Chalifoux, L. V., and King, N. W. (1985) Induction of AIDSlike disease in macaque monkeys with T-cell tropic retrovirus STLV-III. Science 230, 71-73
73. Liu, M., Davies, M. E., Perry, H., Yasutami, Y., Letvin, N., Ulmer, J., Donnelly, J., and Shiver, J. (1994) Immune responses to influenza and HIV-1 proteins elicited by DNA vaccination. Seventh Annual Meeting of the National Cooperative Vaccine Development Groups for AIDS 58
74. Ljunggren, K., Biberfeld, G., Jondal, M., and Fenyoe, E. M. (1989a) Antibody-dependent cellular cytotoxicity detects type-and strain-specific antigens among human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus SIVmac isolates. J. Virol. 63, 3376-3381
75. Ljunggren, K., Boettiger, B., Biberfeld, G., Karlson, A., Fenyoe, E. M., and Jondal, M. (1987a) Antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus. Presence at different clinical stages. J. Immunol. 139, 2263-2267
76. Ljunggren, K., Chiodi, F., Broliden, P. A., Albert, J., Norkrans, G., Hagberg, L., Jondal, M., and Fenyoe, E. M. (1989b) HIV-1-specific antibodies in cerebrospinal fluid mediate cellular cytotoxicity and neutralization. AIDS Res. Hum. Retroviruses 5, 629-638
77. Ljunggren, K., Fenyoe, E. M., Biberfeld, G., and Jondal, M. (1987b) Detection of antibodies which mediate human immunodeficiency virus-specific cellular cytotoxicity (ADCC) in vitro. J. Immunol. Methods. 104, 7-14
78. Louwagie, J., Janssens, W., Mascóla, J., Heyndrickx, L., Hegerich, P., van der Groen, G., Mccutchan, F. E., and Burke, D. S. (1995) Genetic diversity of the envelope glycoprotein from human immunodeficiency virus type 1 isolates of African origin. J. Virol. 69, 263-271
79. Lowenstine, L. J., Pedersen, N. C., Higgins, J., Pallis, K. C., Uyeda, A., Marx, P., Lerche, N. W., Munn, R. J., and Gardner, M. B. (1986) Seroepidemiologic survey of captive Old-World primates for antibodies to human and simian retroviruses, and isolation of a lentivirus from sooty mangabeys (Cercocebus atys). Int J Cancer 38, 563-574
80. Lu, S., Robinson, H., Mustafa, F., Johnson, E., Santoro, J. C., Arthos, J., Winsink, J., Mullins, J. I., Montefiori, D., Yasuhari, Y., Letvin, N., Haynes, J. R., K., M., and Wyand, M. (1994) Simian immunodeficiency virus DNA vaccine trial in macaques. Seventh Annual Meeting of the National Cooperative Vaccine Development Groups for AIDS 60
81. Lübeck, M. D., Natuk, R. J., Chengalvala, M., Chanda, P. K., Murthy, K. K., Murthy, S., Mizutani, S., Lee, S. G., Wade, M. S., Bhat, B. M., Bhat, R., Dheer, S. K., Eichberg, J. W., Davis, A. R., and Hung, R P. (1994) Immunogenicity of recombinant adenovirus-human immunodeficiency virus vaccines in chimpanzees following intranasal administration. AIDS Res. Hum. Retroviruses 10, 1443-1449
82. Luciw, P. A., Potter, S. J., Steimer, K., Dina, D., and Levy, J. A. (1984) Molecular cloning of AIDS-associated retrovirus. Nature 312, 760-763
83. Marschang, P., Sodroski, J., Wurzner, R., and Dierich, M. P. (1995) Decay-accelerating factor (CD55) protects human immunodeficiency virus type 1 from inactivation by human complement. Eur. J. Immunol. 25, 285-290
84. Martinon, F., Krishnan, S., Lenzen, G., Magne, R., Gomard, E. et al. (1993) Induction of virusspecific cytotoxic T-lymphocytes by liposome entrapped messenger RNA. Eur. J. Immunol. 23, 1719-1722
85. Matsushita, S., Robert-Guroff, M., Rusche, J., Koito, A., Hattorf, T., Hoshino, H., Javaherian, K., Takatsuki, K., and Putney, S. (1988) Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope. J. Virol. 62, 2107-2114
86. McClure, H. M., Anderson, D. C., Fultz, P. N., Ansari, A. A., Jehuda-Cohen, T., Villinger, F., Klumpp, S. A., Switzer, W., Lockwood, E., Brodie, A., and Keyserling, H. (1991) Maternal transmission of SIVsmm in rhesus macaques. J. Med. Primatol. 20, 182-187
87. Mertens, T. E., Burton, A., Stoneburner, R. et al (1994) Global estimates and epidemiology of HIV infections and AIDS. AIDS 8 (suppl 1), S361-S372
88. Montefiori, D. C., Graham, B. S., Zhou, J., Zhou, J., Bucco, R. A., Schwartz, D. H., Cavacini, L. A., and Posner, M. R. (1993) V3-specific neutralizing antibodies in sera from HIV-1 gpl60-immunized volunteers block virus fusion and act synergistically with human monoclonal antibody to the conformation-dependent CD4 binding site of gpl20. NIH-NIAID AIDS Vaccine Clinical Trials Network. J Clin Invest 92, 840-847
89. Montgomery, D. L., Shiver, J. W., Leander, K. R., Perry, H. C., Friedman, A., Martinez, D., Ulmer, J. B., Donnelly, J. J., and Liu, M. A. (1993) Heterologous and homologous protection against influenza A by DNA vaccination: optimization of DNA vectors. DNA Cell Biol 12, 777-783
90. Moore, J. P., Cao, Y. Z., Qing, L., Sattentau, Q. J., Pyati, J., Koduri, R., Robinson, J., Barbas, C. F., Burton, D. R., and Ho, D. D. (1995) Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gpl20, and their neutralization is not predicted by studies with monomelic gpl20. J. Virol. 69, 101-109
91. Moore, J. P. and Ho, D. D. (1993) Antibodies to discontinuous or conformationally sensitive epitopes on the gpl20 glycoprotein of human immunodeficiency virus type 1 are highly prevalent in sera of infected humans. J. Virol. 67, 863-875
92. Morton, W. R., Schmidt, A., McClure, J., Hu, S. L., Thompson, J., Tsai, C. C., and Anderson, D. (1994) HIV-2/EH0287: A pathogenic model in macaca nemestrina, Conference on advances in AIDS vaccine development. Seventh annual meeting of the National Cooperative Vaccine Development Groups for AIDS
93. Murphey-Corb, M., Martin, L. N., Davison-Fairburn, B., Montelaro, R. C., Miller, M., West, M., Ohkawa, S., Baskin, G. B., Zhang, J. Y., Putney, S. D., Allison, A. C., and Eppstein, D. A. (1989) A formalin-inactivated whole SIV vaccine confers protection in macaques. Science 246, 1293-1297
94. Myers, G., Maclnnes, K., and Korber, B. (1992) The emergence of simian/human immunodeficiency viruses. AIDS Res. Hum. Retroviruses 8, 373-386
95. Myers, G., Rabson, A. B., Berzofsky, J. A., Smith, T. F., and Wong-Staal, F. (1991) Human Retroviruses and AIDS. Los Alamos National Laboratory, Los Alamos
96. Nara, P. L., Robey, W. G., Gonda, M. A., Carter, S. G., and Fischinger, P. J. (1987) Absence of cytotoxic antibody to human immunodeficiency virus-infected cells in humans and its induction in animals after infection or immunization with purified envelope glycoprotein gpl20. Proc. Natl. Acad. Sci. USA 84, 3797-3801
97. Nara, P. L., Smit, L., Dunlop, N., Hatch, W., Merges, M., Waters, D., Kelliher, J., Gallo, R. C., Fischinger, P. J., and Goudsmit, J. (1990) Emergence of viruses resistant to neutralization by V3-specific antibodies in experimental human immunodeficiency virus type 1IIIB infection of chimpanzees. J. Virol. 64, 3779-3791
98. Natuk, R. J., Chanda, P. K., Lübeck, M. D., Davis, A. R., Wilhelm, J., Hjorth, R., Wade, M. S., Bhat, B. M., Mizutani, S., Lee, S., Eichberg, J., Gallo, R. C., Hung, P. P., and Robert-Guroff, M. (1992) Adenovirus-human immunodeficiency virus (HIV) envelope recombinant vaccines elicit high-titered HIV-neutralizing antibodies in the dog model. Proc. Natl. Acad. Sci. USA 89, 7777-7781
99. Natuk, R. J., Lübeck, M. D., Chanda, P. K., Chengalvala, M., Wade, M. S., and Murthy, S. C. (1993) Immunogenicity of recombinant human adeno virus-human immunodeficiency virus vaccines in chimpanzees. AIDS Res. Hum. Retroviruses 9, 395-404
100. Natuk, R. J., Wade, M. S., Chengalvala, M., Murthy, K. K., Chanda, P. K., Murthy, S. C. S., Bhat, B. M., Bhat, R., Dheer, S. K., Mizutani, S., Lee, S. G., Davis, A. R., Hung, P. P., Lübeck, M. D., and Eichberg, J. W. (1995) Adenovirus as vector for HIV: Efficacy and safety issues. Non Target Effects of Live Vaccines 84, 153-156
101. Nixon, D. F., Townsend, A. R., Elvin, J. G., Rizza, C. R., Gallwey, J., and McMichael, A. J. (1988) HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides. Nature 336, 484-487
102. Norley, S., Beer, B., König, H., Jensen, F., and Kurth, R. (1996) SIVraac vaccine studies using whole inactivated virus antigen sequentially depleted of viral proteins. Vaccine Submitted
103. Norley, S. G., Beer, B., Binninger-Schinzel, D., Cosma, C., and Kurth, R. (1994) Protection from SIVmac challenge following short-term infection with a nef-deficient attenuated virus. Seventh Annual Meeting of the National Cooperative Vaccine Development Groups for AIDS 213
104. Norley, S. G., Mikschy, U., Werner, A., Staszewski, S., Helm, E. B., and Kurth, R. (1990) Demonstration of cross-reactive antibodies able to elicit lysis of both HIV-1-and HIV-infected cells. J. Immunol. 145, 1700-1705
105. Norley, S. G., and Wardley, R. C. (1983) Effector mechanisms in the pig. Antibody-dependent cellular cytolysis of African swine fever virus infected cells. Res Vet Sci 35, 75-79
106. Oldstone, M. B. A. (1994) Cytotoxic T-lymphocytes in human viral and malaria infections. Current Topics in Microbiology and Immunology 189
107. Pialoux, G., Excler, J. L., Riviere, Y., Gonzalezcanali, G., Feuillie, V., Coulaud, P., Gluckman, J. C., Matthews, T. J., Meignier, B., Kieny, M. P., Gönnet, P., Diaz, I., Meric, C., Paoletti, E., Tartaglia, J., Salomon, H., and Plotkin, S. (1995) A prime-boost approach to HIV preventive vaccine using a recombinant canarypox virus expressing glycoprotein 160 (MN) followed by a recombinant glycoprotein 160 (MN/LAI). AIDS Res. Hum. Retroviruses 11, 373-381
108. Picard, O., Achour, A., Bernard, J., Halbreich, A., Bizzini, B., Boyer, V., Desgranges, C., Bertho, J. M., Lachgar, A., Polliotti, B., Defer, M. C., Lanneval, K., Imbert, J. C., Frottier, J., Salaun, J. J., Burney, A., and Zagury, D. (1992) A 2-year follow-up of an anti-HIV immune reaction in HIV-1 gpl60-immunized healthy seronegative humans: evidence for persistent cell-mediated immunity. J. AIDS 5, 539-546
109. Posner, M. R., Elboim, H. S., Cannon, T., Cavacini, L., and Hideshima, T. (1992) Functional activity of an HIV-1 neutralizing IgG human monoclonal antibody: ADCC and complementmediated lysis. AIDS Res. Hum. Retroviruses 8, 553-558
110. Prince, A. M., Moor-Jankowski, J., Eichberg, J. W., Schellekens, H., Mauler, R. F., Girard, M., and Goodall, J. (1988) Chimpanzees and AIDS research. Nature 333, 513
111. Putkonen, P., Boettiger, B., Warstedt, K., Thorstensson, R., Albert, J., and Biberfeld, G. (1989) Experimental infection of cynomolgus monkeys (Macaca fascicularis) with HIV-2. J. AIDS 2, 366-373
112. Putkonen, P., Thorstensson, R., Ghavamzadeh, L., Albert, J., Hild, K., Biberfeld, G., and Norrby, E. (1991) Prevention of HIV-2 and SIVsm infection by passive immunization in cynomolgus monkeys. Nature 352, 436-438
113. Putney, S. D., Matthews, T. J., Robey, W. G., Lynn, D. L., Robert-Guroff, M., Mueller, W. T., Langlois, A. J., Ghrayeb, J., Petteway, S. R., Weinhold, K. J., Fischinger, P. J., Wong-Staal, F., Gallo, R. C., and Bolognesi, D. P. (1986) HTLV-III/LAV-neutralizing antibodies to an E. coli-produced fragment of the virus envelope. Science 234, 1392-1395
114. Reimann, K. A., Tenner-Racz, K., Racz, P., Montefiori, D. C., Yasutomi, Y., Lin, W., Ransil,P. J., and Letvin, N. L. (1994) Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus of macaques. J. Virol. 68, 2362-2370
115. Robert-Guroff, M., Brown, M., and Gallo, R. C. (1985) HTLV-III-neutralizing antibodies in patients with AIDS and AIDS-related complex. Nature 316, 72-74
116. Robey, W. G., Safai, B., Oroszlan, S., Arthur, L. O., Gonda, M. A., Gallo, R. C., and Fischinger, P. J. (1985) Characterization of envelope and core structural gene products of HTLV-III with sera from AIDS patients. Science 228, 593-595
117. Robinson, H. L., Hunt, L. A., and Webster, R. G. (1993) Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA. Vaccine 11, 957-960
118. Sarngadharan, M. G., diMarzo Veronese, F., Lee, S., and Gallo, R. C. (1985) Immunological properties of HTLV-III antigens recognized by sera of patients with AIDS and AIDS-related complex and of asymptomatic carriers of HTLV-III infection. Cancer Res 45, 4574-4577
119. Sawyer, L. S., Wrin, M. T., Crawford-Miksza, L., Potts, B., Wu, Y., Weber, P. A., Alfonso, R. D., and Hanson, C. V. (1994) Neutralization sensitivity of human immunodeficiency virus type 1 is determined in part by the cell in which the virus is propagated. J. Virol. 68, 1342-1349
120. Schultz, A. M. and Stott, E. J. (1994) Primate models for AIDS vaccines. AIDS 8 (suppl. 1), 203-212
121. Schwartz, D. H., Gorse, G., Clements, M. L., Belshe, R., Izu, A., Duliege, A. M., Berman, P., Twaddell, T., Stablein, D., Sposto, R., Siliciano, R., and Matthews, T. (1993) Induction of HIV-1-neutralising and syncytium-inhibiting antibodies in uninfected recipients of HI V-1IIIB rgpl20 subunit vaccine. Lancet 342, 69-73
122. Shafferman, A., Jährling, P. B., Benveniste, R. E., Lewis, M. G., Phipps, T. J., Eden-McCutchan, F., Sadoff, J., Eddy, G. A., and Burke, D. S. (1991) Protection of macaques with a simian immunodeficiency virus envelope peptide vaccine based on conserved human immunodeficiency virus type 1 sequences. Proc. Natl. Acad. Sci. USA 88, 7126-7130
123. Shafferman, A., Lewis, M. G., McCutchan, F. E., Benveniste, R. E., Jährling, P. B., Hickman, R. L., Lai, C. Y., Burke, D. S., and Eddy, G. A. (1992) Vaccination of macaques with SIV conserved envelope peptides suppressed infection and prevented disease progression and transmission. AIDS Res. Hum. Retroviruses 8, 1483-1487
124. Shore, S. L., Nahmias, A. J., Starr, S. E., Wood, P. A., and McFarlin, D. E. (1974) Detection of cell-dependent cytotoxic antibody to cells infected with herpes simplex virus. Nature 251, 350-352
125. Siegel, F., Kurth, R., and Norley, S. (1995) Neither whole inactivated virus immunogen nor passive immunoglobulin transfer protect against SIVagm infection in the African green monkey natural host. J. AIDS 8, 217-226
126. Spear, G. T., Takefman, D. M., Sullivan, B. L., Landay, A. L., and Zolla, P. S. (1993) Complement activation by human monoclonal antibodies to human immunodeficiency virus. J. Virol. 67, 53-59
127. Stahl-Hennig, C., Herchenroeder, O., Nick, S., Evers, M., Stille-Siegener, M., Jentsch, K. D., Kirchhoff, F., Tolle, T., Gatesman, T. J., Lueke, W., and Hunsmann, G. (1990) Experimental infection of macaques with HIV-2ben, a novel HIV-2 isolate. AIDS 4, 611-617
128. Steimer, K. S., Scandella, C. J., Skiles, P. V., and Haigwood, N. L. (1991) Neutralization of divergent HIV-1 isolates by conformation-dependent human antibodies to Gpl20. Science 254, 105-108
129. Steimer, K. S., Sinangil, F., Kahn, J., Chernoff, D., Duliege, A. M., and Baenziger, J. (1994) Primary isolate neutralizing activity of human antibodies directed to recombinant native HIVSF2 gpl20 (rgpl20SF2). AIDS Res. Hum. Retroviruses 10 (suppl 2), S55
130. Stott, E. J., Chan, W. L., Mills, K. H., Page, M., Taffs, F., Cranage, M., Greenaway, P., and Kitchin, P. (1990) Preliminary report: protection of cynomolgus macaques against simian immunodeficiency virus by fixed infected-cell vaccine. Lancet 336, 1538-1541
131. Stott, E. J., Kitchin, P., and Mills, K. (1993) The role of cellular and viral antigens in protection against SIV infection in macaques. IX International Conference on AIDS / IV STD World Congress Abstract WS-A23-2
132. Stott, E. J., Kitchin, P. A., Page, M., Flanagan, B., Taffs, L. F., Chan, W. L., Mills, K. H. G., Silvera, P., and Rodgers, A. (1991) Anti-cell antibody in macaques. Nature 353, 393
133. Sutter, G. and Moss, B. (1995) Novel vaccinia vector derived from the host range restricted and highly attenuated MVA strain of vaccinia virus. Non Target Effects of Live Vaccines 84, 195-200
134. Toth, F. D., Kiss, J., Szabo, B., Fust, G., Ujhelyi, E., Hollan, S. R., and Vaczi, L. (1989) Complement-dependent cytotoxicity of antibodies reactive with HIV-induced cell surface antigens in HIV-carrying haemophiliacs. Acta Virol 33, 521-526
135. Ulmer, J. B., Deck, R. R., Dewitt, C. M., Friedman, A., Donnelly, J. J., and Liu, M. A. (1994) Protective immunity by intramuscular injection of low doses of influenza virus DNA vaccines. Vaccine 12, 1541-1544
136. Ulmer, J. B., Donelly, J. J., Parker, S. E., Rhodes, G. H., Feigner, P. L., Dwarki, V. J., Gromkowski, S. H., Deck, R. R., De Witt, C. M., Friedman, A., Hawe, L. A., Leander, K. R., Martinez, D., Perry, H. C., Shiver, J. W., Montgomery, D. L., and Liu, M. A. (1993) Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259, 1745-1749
137. Velia, C., Minor, P. D., Weller, I. V., Jenkins, O., Evans, D., and Almond, J. (1991) Recognition of poliovirus/HIV chimaeras by antisera from individuals with HIV infection. AIDS 5, 425-430
138. Veronese, F. D., De Vico, A. L., Copeland, T. D., Oroszlan, S., Gallo, R. C., and Sarngadharan, M. G. (1985) Characterization of gp41 as the transmembrane protein coded by the HTLV-III/ LAV envelope gene. Science 229, 1402-1405
139. Villinger, F., Powell, J. D., Jehuda-Cohen, T., Neckelmann, N., Vuchetich, M., De, B., Folks, T. M., McClure, H. M., and Ansari, A. A. (1991) Detection of occult simian immunodeficiency virus SlVsmm infection in asymptomatic seronegative nonhuman primates and evidence for variation in SIV gag sequence between in vivo-and in vitro-propagated virus. J. Virol. 65, 1855-1862
140. Vogel, T., Beer, B., zur Megede, J., Ihlenfelds H. G., Jung, G., Kurth, R., and Norley, S. (1996) Induction of anti-SIVmac cellular and humoral immune responses in rhesus macaques by peptide immunogens: Reduction of virus load following challenge. J. Virol (Submitted)
141. Vogel, T., Kurth, R., and Norley, S. (1994) The majority of neutralizing Abs in HIV-1-infected patients recognize linear V3 loop sequences. Studies using HIV-1MN multiple antigenic peptides. J. Immunol. 153, 1895-1904
142. Walker, B. D., Flexner, C., Birch-Limberger, K., Fisher, L., Paradis, T. J., Aldovini, A., Young, R., Moss, B., and Schooley, R. T. (1989) Long-term culture and fine specificity of human cytotoxic T-lymphocyte clones reactive with human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 86, 9514-9518
143. Walker, B. D. and Plata, F. (1990) Cytotoxic T lymphocytes against HIV. AIDS 4, 177-184
144. Walker, M. C. and Fast, P. E. (1994) Clinical trials of candidate AIDS vaccines. AIDS 8 (suppl 1), S213-S236
145. Wang, C. Y., Looney, D. J., Li, M. L., Walfield, A. M., Ye, J., Hosein, B., Tarn, J. P., and Wong-Staal, F. (1991) Long-term high-titer neutralizing activity induced by octameric synthetic HIV-1 antigen. Science 254, 285-288
146. Weber, J., Cheinsongpopov, R., Callow, D., Adams, S., Patou, G., Hodgkin, K. and Martin, S. (1995) Immunogenicity of the yeast recombinant pl7/p242:Ty virus-like particles (p24-VLP) in healthy volunteers, Vaccine 13, 831-834
147. Webster, R. G., Fynan, E. F., Santoro, J. C., and Robinson, H. (1994) Protection of ferrets against influenza challenge with a DNA vaccine to the haemagglutinin. Vaccine 12, 1495-1498
148. Wyand, M. S., Manson, K., and Desrosiers, R. C. (1994) Vaccine protection against pathogenic SIVmac251 using live-attenuated vaccines SIV239 Δ3 and SIV316 Anef. Seventh Annual Meeting of the National Cooperative Vaccine Development Groups for AIDS 109
149. Yasutomi, Y., Palker, T. J., Gardner, M. B., Haynes, B. F., and Letvin, N. L. (1994) Synthetic peptide in mineral oil adjuvant elicits simian immunodeficiency virus-specific CD8+ cytotoxic T-lymphocytes in rhesus macaques. J. Immunol. 151, 5096-5105
150. Yefenof, E., Asjo, B., and Klein, E. (1991) Alternative complement pathway activation by HIV infected cells: C3 fixation does not lead to complement lysis but enhances NK sensitivity. Int Immunol 3, 395-401
151. Yilma, T., Ahmad, S., McChesney, M., Marthas, M., Kluge, J. D., Bartz, C., Morton, W, Nolte, R., Gardner, M., Luciw, P., and Giavedoni, L. (1994) Protection studies in macaques immunized with vaccinia virus recombinants, subunit antigens, and live attenuated SIVmac239Anef and SIVmac239Anef-IFN-gamma. Seventh Annual Meeting of the National Cooperative Vaccine Development Groups for AIDS
152. Zagury, D., Bernard, J., Cheynier, R., Desportes, I., Leonard, R., Fouchard, M., Reveil, B., Ittele, D., Lurhuma, Z., Mbayo, K., Wane, J., Salaun, J. J., Goussard, B., Dechazal, L., Burney, A., Nara, P., and Gallo, R. C. (1988) A group specific anamnestic immune reaction against HIV-1 induced by a candidate vaccine against AIDS. Nature 332, 728-731
153. Ziegner, U., Peters, G., Jolly, D. J., Mento, S. J., Galpin, J., Prussak, C. E., Barber, J. R., Hartnett, D. E., Bohart, C., Klump, W., Sajjadi, N., Merchant, B., and Warner, J. F. (1995) Cytotoxic T-lymphocyte induction in asymptomatic HIV-1-infected patients immunized with Retrovector((R)) transduced autologous fibroblasts expressing HIV-1 (HIB) Env/Rev proteins. AIDS 9, 43-50